Van Eck Associates Corp Cytokinetics Inc Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 54,364 shares of CYTK stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,364
Previous 71,691
24.17%
Holding current value
$2.26 Million
Previous $3.8 Million
32.75%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CYTK
# of Institutions
416Shares Held
128MCall Options Held
4.57MPut Options Held
2.42M-
Black Rock Inc. New York, NY14.7MShares$611 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$496 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$403 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$328 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$257 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.92B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...